NRx Pharmaceuticals

Wilmington, United States

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

Jun 2026

Post-IPO Equity

Biopharma Biotechnology Health Care Pharmaceutical Therapeutics

Top Investors

Venture 76B CapitalColumbia Threadneedle InvestmentsStreeterville CapitalAnson Funds

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NRx Pharmaceuticals

Who are NRx Pharmaceuticals's investors?

NRx Pharmaceuticals's investors include Venture 76, B Capital, Columbia Threadneedle Investments, Streeterville Capital, Anson Funds.

Where is NRx Pharmaceuticals headquartered?

NRx Pharmaceuticals is headquartered in Wilmington, United States.

What does NRx Pharmaceuticals do?

NRx Pharmaceuticals is a pharmaceutical company developing therapeutics for the treatment of central nervous system disorders.

What stage is NRx Pharmaceuticals at?

NRx Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 3, 2026.

MLA

"NRx Pharmaceuticals — Funding & Investors." VCBacked, June 3, 2026, https://www.vcbacked.co/company/nrx-pharmaceuticals. Accessed June 30, 2026.

APA

VCBacked. (2026). NRx Pharmaceuticals — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/nrx-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=NRx Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/nrx-pharmaceuticals |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 3, 2026.

Similar Companies in Biopharma

Mineralys Therapeutics